Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1999Clinical TherapeuticsOpen Access

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMarvin M. GoldenbergMarion General Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Marvin M. Goldenberg (1999) studied this question.

synapsesocial.com/papers/6aa3cd225b183923dd1aabfehttps://doi.org/10.1016/s0149-2918(00)88288-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.1996 · 1,397 citations
  2. 2Cancer statistics, 19981998 · 2,384 citations